Asia FX muted, dollar weakens slightly ahead of Fed rate decision
Investing.com - Clover Health Investments (NASDAQ: CLOV) reported fourth quarter EPS of $-0.0400, $0.03 better than the analyst estimate of $-0.0700. Revenue for the quarter came in at $330.7M versus the consensus estimate of $348.04M.
Guidance
Clover Health Investments sees FY 2025 revenue of $1.8000B-$1.8700B versus the analyst consensus of $1.6200B.
Clover Health Investments’s stock price closed at $4.14. It is up 18.9700% in the last 3 months and up 381.1200% in the last 12 months.
Clover Health Investments saw 0 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See Clover Health Investments’s stock price’s past reactions to earnings here.
According to InvestingPro, Clover Health Investments’s Financial Health score is "great performance".
Check out Clover Health Investments’s recent earnings performance, and Clover Health Investments’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar